Table 5.

Comparison of complications between male and female patients

	Males (n = 101)	Females (n = 94)	P-value
Cardiologic complications	23 (22.8%)	22 (23.4%)	0.4723
Sepsis	17 (16.8%)	41 (43.6%)	< 0.0001
Surgical complications	37 (36.6%)	29 (30.9%)	0.2020
AKI	24 (25.2%)	2 (2.1%)	< 0.0001
Age < 65 years	59 (58.4%)	60 (63.8%)	0.3837
Age ≥ 65 years	42 (41.6%)	34 (36.2%)	0.3837
Small resection	6 (5.9%)	20 (21.3%)	< 0.0001
Large resection	73 (72.3%)	34 (36.2%)	< 0.0001
RFA	22 (21.8%)	40 (42.6%)	< 0.0001
Benign finding	14 (13.9%)	18 (19.1%)	0.2850
HCC	12 (11.9%)	4 (4.3%)	0.0055
Cholangiocarcinoma	12 (11.9%)	15 (16%)	0.2637
MTS of colorectal carcinoma	45 (44.6%)	19 (20,2%)	< 0.0001
Neuroendocrine tumors	7 (6.9%)	6 (6.4%)	0.8114
Other	11 (10.9%)	32 (34%)	< 0.0001
Duration of surgery (min)	227 ± 106	212 ± 92	0.1364
Perioperative blood loss (ml)	580 ± 532	460 ± 427	0.0146
Substitution of FFP (ml)	480 ± 473	390 ± 358	0.0351

AKI acute kidney injury, RFA radiofrequency ablation, HCC hepatocellular carcinoma, MTS metastases, FFP fresh blood plasma